Putting the award page together from the records…
Putting the award page together from the records…
NCI OPERATIONAL TASK ORDER
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
85 subawards totaling $116.01M (19.0% of what was obligated), as Leidos Biomedical Research Inc reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| American Type Culture Collection | $58.55M | 1 | VA | 2024-01-26 | 2024-01-26 |
| The University of Chicago | $32.97M | 5 | IL | 2023-08-31 | 2024-08-31 |
| Fisher Bioservices Inc | $11.05M | 1 | MD | 2024-08-06 | 2024-08-06 |
| Franklin Young International, Incorporated | $1.98M | 6 | CA | 2023-05-04 | 2023-07-25 |
| Danaher Corp | $1.89M | 9 | CA, IL, MA | 2022-12-01 | 2024-08-01 |
| Pacific Biosciences of California, Inc | $1.45M | 2 | CA | 2023-03-03 | 2023-08-03 |
| Government Scientific Source Inc | $1.06M | 8 | VA | 2022-11-22 | 2024-07-31 |
| Memorial Sloan-Kettering Cancer Center | $790.8K | 1 | NY | 2023-06-27 | 2023-06-27 |
| ST Jude Children'S Research Hospital Inc | $487.8K | 1 | TN | 2023-11-29 | 2023-11-29 |
| Thermo Fisher Scientific Inc. | $468.1K | 1 |
23 actions since 2022-12-19. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-18 | P00045 | Funding only | -$10.8K | FY26 UDO INITIATIVE - NCI OPERATIONAL TASK ORDER FY20 - FY23 |
| 2024-09-06 | P00044 | Funding only | $0 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-08-31 | P00043 | Administrative change | $29.23M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-08-27 | P00042 | Funding only | $33.37M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-08-13 | P00041 | Funding only | -$11.37M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-07-19 | P00040 | Administrative change | $7.36M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-06-26 | P00039 | Administrative change | $40.09M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
| OR |
| 2023-05-01 |
| 2023-05-01 |
| Bso Network, Inc. | $457.7K | 1 | NJ | 2023-10-16 | 2023-10-16 |
| Arc3 Gases, Inc. | $408.5K | 2 | VA | 2023-10-05 | 2023-10-10 |
| Tecan U.S. Group Inc. | $308.0K | 1 | NC | 2023-07-01 | 2023-07-01 |
| Formulatrix, LLC | $307.6K | 2 | MA | 2023-11-08 | 2024-07-25 |
| Total Resource Management Inc | $306.8K | 2 | VA | 2023-04-14 | 2023-04-20 |
| Lumicks USA Inc | $298.2K | 1 | MA | 2023-01-30 | 2023-01-30 |
| Nikon Instruments Inc | $293.8K | 2 | NY | 2023-04-04 | 2023-05-10 |
| Ramona Optics Inc | $267.6K | 1 | NC | 2023-06-21 | 2023-06-21 |
| Daikin Industries, LTD. | $222.9K | 2 | MN | 2023-04-25 | 2024-06-24 |
| Fresenius Se | $220.0K | 1 | IL | 2023-07-27 | 2023-07-27 |
| Atila Biosystems Incorporated | $215.4K | 5 | CA | 2023-03-06 | 2023-03-06 |
| Roche Holding Ag | $181.4K | 1 | IN | 2024-07-16 | 2024-07-16 |
| RCG of North Carolina, LLC | $141.5K | 2 | NC | 2023-09-28 | 2023-10-02 |
| Thermo Electron Corporation | $139.8K | 1 | WI | 2023-06-15 | 2023-06-15 |
| Azure Biosystems Inc | $138.1K | 2 | CA | 2023-06-02 | 2024-05-14 |
The 25 largest of 47; the rest are on USAspending.gov.
| Date | To | Amount | For |
|---|---|---|---|
| 2024-01-26 | American Type Culture Collection | $58.55M | MANAGEMENT OF THE NCI AT FREDERICK CENTRAL REPOSITORY LOCATIONS. |
| 2024-08-31 | The University of Chicago | $13.22M | GDC IMPLEMENTATION |
| 2023-08-31 | The University of Chicago | $11.61M | GDC IMPLEMENTATION |
| 2024-08-06 | Fisher Bioservices Inc | $11.05M | PROVIDE BIOLOGICAL, CGMP CELL BANK STORAGE, ANALYTICAL SERVICES AND CLINICAL MANAGEMEN |
| 2023-08-31 | The University of Chicago | $3.43M | GDC HARDWARE REFRESH |
| 2024-08-31 | The University of Chicago | $2.77M | GDC HARDWARE REFRESH |
| 2023-08-31 | The University of Chicago | $1.95M | GDC IMPLEMENTATION |
| 2023-08-03 | Pacific Biosciences of California, Inc | $849.0K | PURCHASE OF HIGH THROUGHPUT SEQUENCING INSTRUMENT |
| 2023-06-27 | Memorial Sloan-Kettering Cancer Center | $790.8K | THE SUBCONTRACTOR WILL DESIGN, IMPLEMENT, AND MAINTAIN DATA INTAKE PIPELINES FOR DATASETS FROM CRDC REPOSITORIES HTTPS://DATACOMMONS.CANCER.GOV) TO FACILITATE INGESTION INTO THE CBIOPORTAL DATABASE, BEGINNING WITH… |
| 2023-07-25 | Franklin Young International, Incorporated | $616.9K | PURCHASE OF CAPITAL EQUIPMENT/ ECHO SYSTEM |
| 2023-03-03 | Pacific Biosciences of California, Inc | $604.0K | PART # 102-090-600, REVIO SYSTEM INCLUDES THE SEQUENCING INSTRUMENT, PRIMARY ANALYSIS COMPUTE, INSTRUMENT TRAINING AND INSTALLATION |
| 2023-05-04 | Franklin Young International, Incorporated | $579.5K | PURCHASE OF CAPITAL EQUIPMENT/BECKMAN COULTER ECHO LIQUID HANDLING SYSTEM. |
| 2024-02-26 | Molecular Devices LLC | $565.4K | HIGH CONTENT IMAGING SYSTEMS |
| 2023-11-29 | ST Jude Children'S Research Hospital Inc | $487.8K | THE SCOPE OF WORK IS FOR THE DEVELOPMENT OF SCIENTIFIC ANALYSIS TOOLS IN SUPPORT OF THE GDC. |
| 2023-05-01 | Fei Company | $468.1K | SERVICE MAINTENANCE AGREEMENT FOR ELECTRON MICROSCOPES. |
| 2023-10-16 | Bso Network, Inc. | $457.7K | IT CLOUD NETWORK SUPPORT SERVICES |
| 2024-07-01 | Beckman Coulter, Inc. | $441.3K | SERVICE MAINTENANCE AGREEMENT FOR BECKMAN LAB EQUIPMENT |
| 2024-06-14 | Government Scientific Source Inc | $428.9K | CAPITAL EQUIPMENT |
| 2023-07-01 | Beckman Coulter, Inc. | $381.8K | SERVICE MAINTENANCE FOR BECKMAN LAB EQUIPMENT. |
| 2023-06-28 | Franklin Young International, Incorporated | $373.1K | PURCHASE OF CAPITAL EQUIPMENT BIOMEK I7 HYBRID |
| 2023-10-05 | Arcet Equipment Co | $318.5K | INDUSTRIAL GASES. |
| 2023-07-01 | Tecan U.S., Inc. | $308.0K | SERVICE MAINTENANCE AGREEMENT TECAN LAB EQUIPMENT |
| 2023-01-30 | Lumicks USA Inc | $298.2K | PURCHASE OF A Z-MOVI CELL ANALYZER |
| 2023-06-21 | Ramona Optics Inc | $267.6K | PURCHASE OF 2 RAMONA OPTICS MICROSCOPS AND COMPONENTS |
| 2023-10-01 | Leica Microsystems Inc. | $255.4K | SERVICE MAINTENANCE AGREEMENT FOR LAB EQUIPMENT |
| 2024-05-24 | P00038 | Administrative change | $0 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-05-06 | P00037 | Administrative change | $57.99M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-04-02 | P00036 | Administrative change | $0 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2024-03-07 | P00035 | Administrative change | $621.4K | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-12-21 | P00034 | Administrative change | $184.8K | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-10-24 | P00033 | Administrative change | $53.7K | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-09-28 | P00032 | Funding only | $238.38M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-08-30 | P00031 | Option exercised | $69.10M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-08-18 | P00030 | Administrative change | $7.69M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-08-04 | P00029 | Funding only | $19.39M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-07-18 | P00028 | Funding only | $12.90M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-06-23 | P00027 | Funding only | $15.10M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-06-06 | P00026 | Funding only | $28.85M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-03-31 | P00025 | Funding only | $61.16M | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2023-03-20 | P00024 | Administrative change | $0 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |
| 2022-12-19 | P00023 | Administrative change | $0 | THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTENDED USES IN CANCER PATIENTS AND OTHERS. |